Cargando…

A systematic review of amino acid PET in assessing treatment response to temozolomide in glioma

The response assessment in neuro-oncology (RANO) criteria have been the gold standard for monitoring treatment response in glioblastoma (GBM) and differentiating tumor progression from pseudoprogression. While the RANO criteria have played a key role in detecting early tumor progression, their abili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prather, Kiana Y, O’Neal, Christen M, Westrup, Alison M, Tullos, Hurtis J, Hughes, Kendall L, Conner, Andrew K, Glenn, Chad A, Battiste, James D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923003/ https://www.ncbi.nlm.nih.gov/pubmed/35300149 http://dx.doi.org/10.1093/noajnl/vdac008

Ejemplares similares

A systematic review of the utility of amino acid PET in assessing treatment response to bevacizumab in recurrent high-grade glioma
por: Hughes, Kendall L, et al.
Publicado: (2021)

Management of nonoperative cervical spine fractures: An institutional analysis of follow-up duration and image acquisition
por: Westrup, Alison M., et al.
Publicado: (2022)

Myelopathy Improvement Following Removal of Cervical Sublaminar Wiring
por: Tullos, Hurtis J, et al.
Publicado: (2018)

Transfer of extensor carpi radialis brevis branch of radial nerve to anterior interosseous nerve for lower trunk brachial plexopathy after motor vehicle accident
por: Westrup, Alison M., et al.
Publicado: (2023)

Navigated transcranial magnetic stimulation following awake craniotomy for resection of glioma: Description of two cases
por: O’Neal, Christen M., et al.
Publicado: (2020)

Percutaneous Thoracic Spinal Cord Stimulator Placement
por: Westrup, Alison M, et al.
Publicado: (2021)

Temozolomide in malignant glioma
por: Dresemann, Gregor
Publicado: (2010)

Patient Outcomes in Disorders of Consciousness Following Transcranial Magnetic Stimulation: A Systematic Review and Meta-Analysis of Individual Patient Data
por: O'Neal, Christen M., et al.
Publicado: (2021)

Polymorphous low-grade neuroepithelial tumor of the young: Rare tumor and review of the literature
por: Palejwala, Ali H, et al.
Publicado: (2022)

Resolution of symptoms in idiopathic thalamic pain syndrome after implantation of a cervical and thoracic percutaneous spinal cord stimulator
por: Hagerdon, Kylie E., et al.
Publicado: (2021)

Delayed hemorrhage following deep brain stimulation device placement in a patient with Parkinson’s disease and lupus anticoagulant syndrome: illustrative case
por: Walker, Robert B., et al.
Publicado: (2022)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
por: Ohba, Shigeo, et al.
Publicado: (2021)

The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II
por: Smits, Anja, et al.
Publicado: (2011)

Temozolomide Chemotherapy in Patients with Recurrent Malignant Gliomas
por: Yang, Seung-Ho, et al.
Publicado: (2006)

The strategy for enhancing temozolomide against malignant glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2012)

Targeting autophagy to sensitive glioma to temozolomide treatment
por: Yan, Yuanliang, et al.
Publicado: (2016)

Glioma and temozolomide induced alterations in gut microbiome
por: Patrizz, Anthony, et al.
Publicado: (2020)

Temozolomide Chronotherapy in Glioma: A Systematic Review
por: Jia, Jason L., et al.
Publicado: (2023)

Extended-schedule dose-dense temozolomide in refractory gliomas
por: Berrocal, A., et al.
Publicado: (2009)

Piperine synergistically enhances the effect of temozolomide against temozolomide-resistant human glioma cell lines
por: Jeong, Somi, et al.
Publicado: (2020)

Treating malignant glioma in Chinese patients: update on temozolomide
por: Chang, Liang, et al.
Publicado: (2014)

Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma
por: Osman, Mohammed A
Publicado: (2014)

Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)

Depatux-M and temozolomide in advanced high-grade glioma
por: Hirsch, Sophie, et al.
Publicado: (2020)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
por: Hu, Zhifang, et al.
Publicado: (2020)

Imaging temozolomide-induced changes in the myeloid glioma microenvironment
por: Foray, Claudia, et al.
Publicado: (2021)

β-elemene combined with temozolomide in treatment of brain glioma
por: Zhang, Xiaomin, et al.
Publicado: (2021)

Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma
por: Shi, Hui, et al.
Publicado: (2020)

Common Disconnections in Glioma Surgery: An Anatomic Description
por: Glenn, Chad, et al.
Publicado: (2017)

Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas
por: Minea, Radu O., et al.
Publicado: (2020)

Imaging glioma biology: spatial comparison of amino acid PET, amide proton transfer, and perfusion-weighted MRI in newly diagnosed gliomas
por: Schön, S., et al.
Publicado: (2020)

Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
por: Ryu, Chung Heon, et al.
Publicado: (2012)

Carnosic acid potentiates the anticancer effect of temozolomide by inducing apoptosis and autophagy in glioma
por: Shao, Naiyuan, et al.
Publicado: (2018)

The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI
por: Santo, Giulia, et al.
Publicado: (2022)

Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas
por: Kaiser, Lena, et al.
Publicado: (2021)

Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide
por: Kanzawa, T, et al.
Publicado: (2003)

Temozolomide arrests glioma growth and normalizes intratumoral extracellular pH
por: Rao, Jyotsna U., et al.
Publicado: (2017)

Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy
por: Sengupta, Sadhak, et al.
Publicado: (2012)

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells
por: Barciszewska, Anna-Maria, et al.
Publicado: (2015)

Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
por: Daniel, Paul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r0opi613k6mop0ci6b3hjhc6nm